Search

Search bills, members, committees and pages...

H.R. 4639

U.S. HouseIn House Committee

Summary

H.R. 4639, the Infertility Treatment Affordability Act of 2025, was introduced in the House on Jul 23, 2025 by Rep. Mike Carey (R) with 4 co-sponsors. It was referred to Ways And Means, and last saw action on Jul 23, 2025: Referred to the House Committee on Ways and Means.


Record

Text

H.R. 4639 has 4 co-sponsors.

hb4639/introduced-in-house.txt
119 HR 4639 IH: Infertility Treatment Affordability Act of 2025
U.S. House of Representatives
2025-07-23
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 4639 IN THE HOUSE OF REPRESENTATIVES July 23, 2025 Mr. Carey (for himself, Mr. Landsman , and Mr. Miller of Ohio ) introduced the following bill; which was referred to the Committee on Ways and Means A BILL
To amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments.
1.
Short title
This Act may be cited as the Infertility Treatment Affordability Act of 2025 .
2.
Credit for infertility treatments
(a)
In general
Subpart A of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting before section 24 the following new section:
23A.
Credit for infertility treatments
(a)
Allowance of credit
In the case of an eligible individual, there shall be allowed as a credit against the tax imposed by this chapter for the taxable year an amount equal to 50 percent of the qualified infertility treatment expenses paid or incurred during the taxable year.
(b)
Limitations
(1)
Dollar limitation
The amount of the credit under subsection (a) for any taxable year shall not exceed the excess (if any) of—
(A)
the dollar amount in effect under section 23(b)(1) for the taxable year, over
(B)
the aggregate amount of the credits allowed under subsection (a) for all preceding taxable years.
(2)
Income limitation
(A)
In general
The amount otherwise allowable as a credit under subsection (a) for any taxable year (determined after the application of paragraph (1) and without regard to this paragraph and subsection (c)) shall be reduced (but not below zero) by an amount which bears the same ratio to the amount so allowable as—
(i)
the amount (if any) by which the taxpayer’s adjusted gross income exceeds the dollar amount in effect under clause (i) of section 23(b)(2)(A), bears to
(ii)
$40,000.
(B)
Determination of adjusted gross income
For purposes of subparagraph (A), adjusted gross income shall be determined without regard to sections 911, 931, and 933.
(3)
Portion of credit refundable
(A)
In general
So much of the credit allowed under subsection (a) for any taxable year (determined after the applications of paragraphs (1) and (2)) as does not exceed $5,000 shall be treated as a credit allowed under subpart C and not as a credit allowed under this subpart.
(B)
Adjustments for inflation
(i)
In general
In the case of a taxable year beginning after December 31, 2025, the $5,000 amount in subparagraph (A) shall be increased by an amount equal to—
(I)
such dollar amount, multiplied by
(II)
the cost-of-living adjustment determined under section 1(f)(3) for the calendar year in which the taxable year begins, determined by substituting calendar year 2024 for calendar year 2016 in subparagraph (A)(ii) thereof.
(ii)
Rounding
If any amount as increased under clause (i) is not a multiple of $10, such amount shall be rounded to the nearest multiple of $10.
(4)
Denial of double benefit
(A)
In general
Any qualified infertility treatment expense taken into account for purposes of any deduction (or any credit other than the credit allowed under this section) shall be reduced by the amount of the credit allowed under subsection (a) with respect to such expense.
(B)
Grants
No credit shall be allowed under subsection (a) for any expense to the extent that reimbursement or other funds in compensation for such expense are received under any Federal, State, or local program.
(C)
Insurance reimbursement
No credit shall be allowed under subsection (a) for any expense to the extent that payment for such expense is made, or reimbursement for such expense is received, under any insurance policy.
(c)
Carryforwards of unused credit
(1)
In general
If the portion of the credit allowable under subsection (a) which is allowed under this subpart exceeds the limitation imposed by section 26(a) for such taxable year reduced by the sum of the credits allowable under this subpart (other than this section and section 25D), such excess shall be carried to the succeeding taxable year and added to the credit allowable under subsection (a) for such succeeding taxable year.
(2)
Limitation
No credit may be carried forward under this subsection to any taxable year after the 5th taxable year after the taxable year in which the credit arose. For purposes of the preceding sentence, credits shall be treated as used on a first-in, first-out basis.
(d)
Qualified infertility treatment expenses
For purposes of this section—
(1)
In general
The term qualified infertility treatment expenses means amounts paid or incurred for the treatment of infertility if such treatment is provided—
(A)
by a physician, or other medical practitioner, licensed in the United States, and
(B)
pursuant to a diagnosis of infertility by a physician licensed in the United States.
(2)
Treatments in advance of infertility arising from medical treatments
For purposes of this section:
(A)
In general
In the case of expenses incurred in advance of a diagnosis of infertility for fertility preservation procedures which are conducted prior to medical procedures that, as determined by a physician licensed in the United States, may cause involuntary infertility or sterilization, such expenses shall be treated as qualified infertility treatment expenses—
(i)
notwithstanding paragraph (1)(B), and
(ii)
without regard to whether a diagnosis of infertility subsequently results.
(B)
Exception for procedures designed to result in infertility
Expenses for fertility preservation procedures in advance of a procedure designed to result in infertility or sterilization shall not be treated as qualified infertility treatment expenses.
(3)
Infertility
The term infertility —
(A)
means the inability to conceive or to carry a pregnancy to live birth,
(B)
includes iatrogenic infertility resulting from medical treatments such as chemotherapy, radiation, or surgery, and
(C)
does not include infertility or sterilization resulting from a procedure designed for such purpose.
(e)
Eligible individual
For purposes of this section, the term eligible individual means an individual—
(1)
who has been diagnosed with infertility by a physician licensed in the United States, or
(2)
with respect to whom a physician licensed in the United States has made the determination described in subsection (d)(2)(A).
(f)
Married couples must file joint returns
Rules similar to the rules of paragraphs (2), (3), and (4) of section 21(e) shall apply for purposes of this section.
.
(b)
Conforming amendments
(1)
The table of sections for subpart A of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting before the item relating to section 24 the following new item:
Sec. 23A. Credit for infertility treatments.
.
(2)
Section 23(c)(1) of such Code is amended by striking section 25D and inserting sections 23A and 25D .
(3)
Section 25(e)(1)(C) of such Code is amended by inserting , 23A, after 23 .
(c)
Effective date
The amendments made by this section shall apply to taxable years beginning after December 31, 2024.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-07-23
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments.

Sponsors

Rep. Mike Carey (R) sponsors H.R. 4639, and 4 members have co-sponsored it, 2 of them from the day it was introduced.

Committees

H.R. 4639 went before 1 committee: Ways and Means.

Ways and Means
Ways and Means
Referred To · Jul 23, 2025 · 1,160 Bills

Actions

H.R. 4639 has taken 2 actions since Jul 23, 2025.

ChamberAction
Jul 23, 2025
House
Introduced in House
Jul 23, 2025
House
Referred to the House Committee on Ways and Means.Ways and Means Committee

Votes

H.R. 4639 has not gone to a roll call.

Titles

H.R. 4639 goes by 3 titles, 1 of them short titles.

  • Infertility Treatment Affordability Act of 2025 — Display Title
  • To amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments. — Official Title as Introduced
  • Infertility Treatment Affordability Act of 2025 — Short Title(s) as Introduced

Lobbying

3 clients hired 3 firms and 10 registered lobbyists who named H.R. 4639 in 7 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products, Defense.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
FERRING PHARMACEUTICALS, INC.District of Columbia14
EMD SERONO, INC.Client is a biopharmaceutical company.Massachusetts12$100K
DEMAND PROGRESS ACTION, INCMaryland11

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
FERRING PHARMACEUTICALS, INC.14
THE MCMANUS GROUP12$100K
DEMAND PROGRESS ACTION, INC11

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2025 fourth_quarter$290K4th Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2026 second_quarter$250K2nd Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2026 first_quarter$220K1st Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2025 third_quarter$160K3rd Quarter - Report
EMD SERONO, INC.THE MCMANUS GROUP2025 fourth_quarter$50K4th Quarter - Termina…
EMD SERONO, INC.THE MCMANUS GROUP2025 third_quarter$50K3rd Quarter - Report
DEMAND PROGRESS ACTION, INCDEMAND PROGRESS ACTION, INC2025 fourth_quarter$40K4th Quarter - Report

Classification

The Congressional Research Service files H.R. 4639 under Taxation, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 4639’s is Taxation.

hr4639/policy-areas.txt
TaxationAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHealthHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTransportation and Public WorksWater Resources Development

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 4639, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 126 (Wednesday, July 23, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CAREY:H.R. 4639.Congress has the power to enact this legislation pursuantto the following:Article I Section 8[Page H3647]

Source: congress.gov · legiscan.com